May 24, 2013
We are pleased to inform you that Life Chemicals Inc., a leading provider of compound libraries that consist of novel drug-like and lead-like small organic molecules, has just released built by the front-end industry standards Kinase Targeted Screening Library (KTSL) to provide you with good quality hits for your Drug Discovery projects. It was built based on the analysis of nearly 1 000 chemotypes claimed in the literature as kinase inhibitors.
KTSL consists of high quality inhibitors & activators to target key kinases in Cancer and Inflammation: ABL, AKT, AMPK, Aur, CDK, CHK1, CK2, cKIT, ERK, FLT3, GSK3, HER, JAKs, LCK, MEK1, mTOR, p38a, PAK, PDK1, PI3K, PIM, PKM2, PLK1, ROCK, Src, Syk, Tyk2, VEGFR. It will definitely give a boost to your Drug Discovery pipeline, your career and self-confidence.
If you would like to download our Kinase Targeted Screening Library, please follow the link.
All compounds are drug-like, have purity of at least 90 % and do not have any undesired functionalities. Analytical data (LC-MS and/or NMR) for all compounds are available upon request free of charge. Life Chemicals guarantees re-supply and re-synthesis, and will be happy to work with you on lead optimization projects and SAR studies.
Please, contact us to receive more details!